MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 19, 2006; DOI: 10.1124/mol.106.028134


0026-895X/06/7006-1916-1924$20.00
Mol Pharmacol 70:1916-1924, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.028134v1
70/6/1916    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furukawa, T.
Right arrow Articles by Kurokawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furukawa, T.
Right arrow Articles by Kurokawa, J.

Ginsenoside Re, a Main Phytosterol of Panax ginseng, Activates Cardiac Potassium Channels via a Nongenomic Pathway of Sex Hormones

Tetsushi Furukawa, Chang-Xi Bai, Asami Kaihara, Eri Ozaki, Takashi Kawano, Yutaka Nakaya, Muhammad Awais, Moritoshi Sato, Yoshio Umezawa, and Junko Kurokawa

Department of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical and Dental University (T.F., C.-X.B., A.K., E.O., J.K.); Departments of Anesthesiology (T.K.) and Nutrition (Y.N.), Tokushima University School of Medicine; and Department of Chemistry, School of Science, the University of Tokyo, Tokyo, Japan (M.A., M.S., Y.U.)

Ginseng root is one of the most popular herbs throughout the world and is believed to be a panacea and to promote longevity. It has been used as a medicine to protect against cardiac ischemia, a major cause of death in the West. We have previously demonstrated that ginsenoside Re, a main phytosterol of Panax ginseng, inhibits Ca2+ accumulation in mitochondria during cardiac ischemia/reperfusion, which is attributable to nitric oxide (NO)-induced Ca2+ channel inhibition and K+ channel activation in cardiac myocytes. In this study, we provide compelling evidence that ginsenoside Re activates endothelial NO synthase (eNOS) to release NO, resulting in activation of the slowly activating delayed rectifier K+ current. The eNOS activation occurs via a nongenomic pathway of each of androgen receptor, estrogen receptor-{alpha}, and progesterone receptor, in which c-Src, phosphoinositide 3-kinase, Akt, and eNOS are sequentially activated. However, ginsenoside Re does not stimulate proliferation of androgen-responsive LNCaP cells and estrogen-responsive MCF-7 cells, implying that ginsenoside Re does not activate a genomic pathway of sex hormone receptors. Fluorescence resonance energy transfer experiments with a probe, SCCoR (single cell coactivator recruitment), indicate that the lack of genomic action is attributable to failure of coactivator recruitment. Thus, ginsenoside Re acts as a specific agonist for the nongenomic pathway of sex steroid receptors, and NO released from activated eNOS underlies cardiac K+ channel activation and protection against ischemia-reperfusion injury.


Received June 20, 2006; accepted September 19, 2006

Address correspondence to: Dr. Tetsushi Furukawa, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan. E-mail: t_furukawa.bip{at}mri.tmd.ac.jp




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-C. Chang, A. S. Barth, T. Sasano, E. Kizana, Y. Kashiwakura, Y. Zhang, D. B. Foster, and E. Marban
CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart
PNAS, March 18, 2008; 105(11): 4477 - 4482.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Nakamura, J. Kurokawa, C.-X. Bai, K. Asada, J. Xu, R. V. Oren, Z. I. Zhu, C. E. Clancy, M. Isobe, and T. Furukawa
Progesterone Regulates Cardiac Repolarization Through a Nongenomic Pathway: An In Vitro Patch-Clamp and Computational Modeling Study
Circulation, December 18, 2007; 116(25): 2913 - 2922.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics